Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.71 |
| ▸ | GAA | P10253 | 3/20 | 0.71 |
| ▸ | HPGD | P15428 | 3/20 | 0.71 |
| ▸ | MEN1 | O00255 | 3/20 | 0.71 |
| ▸ | MAPT | P10636 | 3/20 | 0.71 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.71 |
| ▸ | ESR1 | P03372 | 3/20 | 0.71 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.71 |
| ▸ | RECQL | P46063 | 2/20 | 0.71 |
| ▸ | BLM | P54132 | 2/20 | 0.71 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.71 |
| ▸ | GLA | P06280 | 2/20 | 0.71 |
| ▸ | MAOA | P21397 | 2/20 | 0.71 |
| ▸ | MGAM | O43451 | 1/20 | 0.71 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.71 |
| ▸ | LMNA | P02545 | 1/20 | 0.71 |
| ▸ | POLB | P06746 | 1/20 | 0.71 |
| ▸ | THRB | P10828 | 1/20 | 0.71 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.71 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29929471 | 1.00 | KDM4E (0.71) | KDM4EGAAHPGDMEN1MAPT | |
| Coumestrol SCHEMBL22012 | 0.84 | ESR2 (1.00) | KDM4EGAAHPGDMEN1MAPT | |
| Coumestrol SCHEMBL29453366 | 0.84 | ESR2 (1.00) | KDM4EGAAHPGDMEN1MAPT | |
| SCHEMBL15870374 | 0.83 | ESR2 (0.84) | KDM4EGAAHPGDMEN1MAPT | |
| SCHEMBL15870375 | 0.81 | KMT2A (0.82) | KDM4EGAAHPGDMEN1MAPT | |
| SCHEMBL30629125 | 0.81 | PKLR (0.69) | KDM4EGAAHPGDMEN1MAPT | |
| SCHEMBL26767167 | 0.81 | PKLR (0.69) | KDM4EGAAHPGDMEN1MAPT | |
| SCHEMBL13692853 | 0.81 | ALDH1A1 (0.51) | KDM4EGAAHPGDMEN1MAPT | |
| SCHEMBL15870371 | 0.77 | KDM4E (0.85) | KDM4EGAAHPGDMEN1MAPT | |
| SCHEMBL234819 | 0.77 | KDM4E (0.85) | KDM4EGAAHPGDMEN1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 131 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240315965-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2024-09-26 | — | — | US | claimed |
| US-20230089351-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2023-03-23 | — | — | US | claimed |
| WO-2022182527-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2022-09-01 | — | — | WO | claimed |
| WO-2022182523-A1 | COMPOSITIONS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2022-09-01 | — | — | WO | claimed |
| WO-2021158573-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2021-08-12 | — | — | WO | claimed |
| WO-2021158575-A1 | COMPOSITIONS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2021-08-12 | — | — | WO | claimed |
| CN-107361214-A | Enzymatic hydrolysis and fermentation alfalfa meal and preparation method thereof | 河南农科牧业有限公司 | 2017-11-21 | — | — | CN | claimed |
| CN-106820113-A | Full clover peptide nutrient food and preparation method thereof | 陕西天宝大豆食品技术研究所 | 2017-06-13 | — | — | CN | claimed |
| CN-104738065-A | Medicagol-containing pesticide composition | WANG BAOYAN | 2015-07-01 | — | — | CN | claimed |
| US-20100306878-A1 | HIGHLY EFFICIENT SUPPRESSOR-DEPENDENT PROTEIN EXPRESSION IN PLANTS WITH A VIRAL VECTOR | BAYLOR UNIVERSITY (US) | 2010-12-02 | — | — | US | claimed |
| US-20260048025-A1 | COMPOSITIONS AND METHODS RELATED TO DISSOLVED OXIDES | NATURAL EXTRACTION SYS LLC (US) | 2026-02-19 | — | — | US | disclosed |
| US-12409152-B2 | Compositions and methods related to dissolved oxides | Natural Extraction Systems, LLC (US) | 2025-09-09 | — | — | US | disclosed |
| US-20250249059-A1 | PLANT BASED HONEY COMPOSITION | Melibio, Inc. | 2025-08-07 | — | — | US | disclosed |
| US-20250213601-A1 | METHODS AND BIOAVAILABLE HIGHLY PERMEABLE COMPOUNDS FOR THE TREATMENT OF VIRAL DISEASES | Didenko, Kirill (US) | 2025-07-03 | — | — | US | disclosed |
| US-20240315965-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2024-09-26 | — | — | US | disclosed |
| EP-1003522-A1 | A METHOD FOR PREVENTING OR CONTROLLING CATARACT | THE UNIVERSITY OF SYDNEY (AU) | 2000-05-31 | — | — | EP | disclosed |
| EP-1003470-A2 | SKIN CARE COMPOSITION | UNILEVER PLC (GB) | 2000-05-31 | — | — | EP | disclosed |
| US-6030620-A | FOR DELIVERING PHYTOESTROGEN TO HUMAN SKIN | CHESEBROUGH-POND'S USA CO., DIVISION OF CONOPCO, INC. (US) | 2000-02-29 | — | — | US | disclosed |
| WO-1999004748-A2 | SKIN CARE COMPOSITION | UNILEVER PLC (GB) | 1999-02-04 | — | — | WO | disclosed |
| WO-1998026784-A1 | A METHOD FOR PREVENTING OR CONTROLLING CATARACT | THE UNIVERSITY OF SYDNEY (AU) | 1998-06-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230089351-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | FABP2, FABP4, GUSB | KDM4E 4637/4885GAA 98/4885HPGD 533/4885 |
| US-12409152-B2 | Compositions and methods related to dissolved oxides | PRKG2, PRKG1, CIT | KDM4E 4365/4885GAA 2468/4885HPGD 317/4885 |
| US-20250213601-A1 | METHODS AND BIOAVAILABLE HIGHLY PERMEABLE COMPOUNDS FOR THE TREATMENT OF VIRAL DISEASES | ACE2, FURIN, SARS1 | KDM4E 2815/4885GAA 1541/4885HPGD 2020/4885 |
| US-20260048025-A1 | COMPOSITIONS AND METHODS RELATED TO DISSOLVED OXIDES | SCO2, CNR2, CNR1 | KDM4E 3795/4885GAA 4777/4885HPGD 329/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.